Programmed death ligand-1 (PDL1) and CD3 co-expression in patients with advanced stage EGFR mutant NSCLC treated with EGFR tyrosine kinase inhibitors (TKI)
Titel:
Programmed death ligand-1 (PDL1) and CD3 co-expression in patients with advanced stage EGFR mutant NSCLC treated with EGFR tyrosine kinase inhibitors (TKI)
Auteur:
Soo, R.A. Kim, H.R. Asuncion, B.R. Fazreen, Z. Omar, M.F.M. Herrera, M.C. Lim, J.S.Y. Sia, G. Soong, R. Cho, B.-C.